OBJECTIVE: To study patient tolerability of brain imaging that employs an ultrahigh field (7 T) MR system METHODS: We examined 180 subjects that underwent brain MR examination at 7 T. A tolerability test consisting of two parts (during patient table motion and during the examination) was administered to all subjects in order to monitor their discomfort. The scores range from 0 to 5 for the first part, and from 0 to 10 for the second part, the total score of each subject therefore ranging from 0 (no side effects reported) to 15 (lowest tolerability) RESULTS: A total of 51% of subjects reported at least one side effect but all were mild in intensity and did not require examination interruption. No serious adverse event was reported. The total score (mean ± standard deviation) was 1.1 ± 1.5 out of 15 (mean score 0.4 ± 0.7 out of 5 during patient table motion and 0.7 ± 1.1 out of 10 during MR). Patient discomfort was not related to gender or health status, but it was reduced with time after system installation with increasing operator experience in performing UHF MR examinations. CONCLUSIONS: Ultrahigh field MRI is well tolerated without excessive discomfort to subjects. KEY POINTS: • 7-T MRI is well tolerated with low incidence of side effects • The subjects' discomfort during 7-T MRI is reduced as the operators' experience increases • 7-T MRI is practicable in healthy subjects and patients with neurodegenerative diseases.
OBJECTIVE: To study patient tolerability of brain imaging that employs an ultrahigh field (7 T) MR system METHODS: We examined 180 subjects that underwent brain MR examination at 7 T. A tolerability test consisting of two parts (during patient table motion and during the examination) was administered to all subjects in order to monitor their discomfort. The scores range from 0 to 5 for the first part, and from 0 to 10 for the second part, the total score of each subject therefore ranging from 0 (no side effects reported) to 15 (lowest tolerability) RESULTS: A total of 51% of subjects reported at least one side effect but all were mild in intensity and did not require examination interruption. No serious adverse event was reported. The total score (mean ± standard deviation) was 1.1 ± 1.5 out of 15 (mean score 0.4 ± 0.7 out of 5 during patient table motion and 0.7 ± 1.1 out of 10 during MR). Patient discomfort was not related to gender or health status, but it was reduced with time after system installation with increasing operator experience in performing UHF MR examinations. CONCLUSIONS: Ultrahigh field MRI is well tolerated without excessive discomfort to subjects. KEY POINTS: • 7-T MRI is well tolerated with low incidence of side effects • The subjects' discomfort during 7-T MRI is reduced as the operators' experience increases • 7-T MRI is practicable in healthy subjects and patients with neurodegenerative diseases.
Authors: Jens M Theysohn; Stefan Maderwald; Oliver Kraff; Christoph Moenninghoff; Mark E Ladd; Susanne C Ladd Journal: MAGMA Date: 2007-12-07 Impact factor: 2.310
Authors: Christina Heilmaier; Jens M Theysohn; Stefan Maderwald; Oliver Kraff; Mark E Ladd; Susanne C Ladd Journal: Bioelectromagnetics Date: 2011-05-19 Impact factor: 2.010
Authors: Maarten J Versluis; Wouter M Teeuwisse; Hermien E Kan; Mark A van Buchem; Andrew G Webb; Matthias J van Osch Journal: J Magn Reson Imaging Date: 2012-11-13 Impact factor: 4.813
Authors: Mauro Costagli; Mark R Symms; Lorenzo Angeli; Douglas A C Kelley; Laura Biagi; Andrea Farnetani; Catarina Rua; Graziella Donatelli; Gianluigi Tiberi; Michela Tosetti; Mirco Cosottini Journal: Eur Radiol Date: 2015-08-29 Impact factor: 5.315
Authors: E Bartolini; M Cosottini; M Costagli; C Barba; L Tassi; R Spreafico; R Garbelli; L Biagi; A Buccoliero; F Giordano; R Guerrini Journal: AJNR Am J Neuroradiol Date: 2019-11-14 Impact factor: 3.825
Authors: M Cosottini; D Frosini; I Pesaresi; G Donatelli; P Cecchi; M Costagli; L Biagi; R Ceravolo; U Bonuccelli; M Tosetti Journal: AJNR Am J Neuroradiol Date: 2014-11-06 Impact factor: 3.825
Authors: Ilias I Giannakopoulos; Jose E C Serralles; Luca Daniel; Daniel K Sodickson; Athanasios G Polimeridis; Jacob K White; Riccardo Lattanzi Journal: IEEE Trans Biomed Eng Date: 2020-12-21 Impact factor: 4.538
Authors: Ilias I Giannakopoulos; Georgy D Guryev; José E C Serrallés; Ioannis P Georgakis; Luca Daniel; Jacob K White; Riccardo Lattanzi Journal: IEEE Trans Antennas Propag Date: 2021-06-25 Impact factor: 4.388
Authors: Giske Opheim; Anja van der Kolk; Karin Markenroth Bloch; Albert J Colon; Kathryn A Davis; Thomas R Henry; Jacobus F A Jansen; Stephen E Jones; Jullie W Pan; Karl Rössler; Joel M Stein; Maria C Strandberg; Siegfried Trattnig; Pierre-Francois Van de Moortele; Maria Isabel Vargas; Irene Wang; Fabrice Bartolomei; Neda Bernasconi; Andrea Bernasconi; Boris Bernhardt; Isabella Björkman-Burtscher; Mirco Cosottini; Sandhitsu R Das; Lucie Hertz-Pannier; Sara Inati; Michael T Jurkiewicz; Ali R Khan; Shuli Liang; Ruoyun Emily Ma; Srinivasan Mukundan; Heath Pardoe; Lars H Pinborg; Jonathan R Polimeni; Jean-Philippe Ranjeva; Esther Steijvers; Steven Stufflebeam; Tim J Veersema; Alexandre Vignaud; Natalie Voets; Serge Vulliemoz; Christopher J Wiggins; Rong Xue; Renzo Guerrini; Maxime Guye Journal: Neurology Date: 2020-12-22 Impact factor: 9.910
Authors: Cezary Grochowski; Mark Symms; Kamil Jonak; Paweł Krukow; Tobias Wood; Emil Ljungberg; Joaquim Enseñat; Katarzyna Nowomiejska; Robert Rejdak; Ryszard Maciejewski; Gareth J Barker Journal: J Clin Med Date: 2020-04-13 Impact factor: 4.241